available for iOS, Android and web
FDA approves Zydelig for three types of blood cancer.
New problems in the generics supply chain
Return to growth postponed
Revenues from MS pill pass $700 million
And med/pharma exports rose 12% in May
Elsewhere, scientists discover more than 80 new genes linked with schizophrenia
Looking at early-treatment option
A waste of time or way forward?
PharmaTimes 2014 Copyright | RSS Feed Subscriptions Software Development by DCSL Software